For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease (Marso et al., 2016a)
Many patients continue receiving important metabolic and cardiovascular benefits even when additional weight loss slows
After you reconstitute the sermorelin powder with bacteriostatic water, its shelf life changes
[...] Rated 5 out of 5 Kelvin GenetexPharma.com is easy to navigate and secure
These new drugs could be life-changing for many who desperately need to lose weight for their health, especially if they can build new habits and optimise their nutrition
This is sometimes referred to as sarcopenic obesity, or "skinny fat." Individuals may appear thin or have a normal body weight but the combination of body fat relative to low muscle mass is associated with increased health risks, similar to those seen in both obesity and sarcopenia (e.g., insulin resistance, type 2 diabetes, cardiovascular disease, and decreased physical function and mobility)